Sherrington Robin - Dec 29, 2023 Form 4 Insider Report for Xenon Pharmaceuticals Inc. (XENE)

Role
EVP, Strategy & Innovation
Signature
/s/ Sherry Aulin, Attorney-in-fact
Stock symbol
XENE
Transactions as of
Dec 29, 2023
Transactions value $
$0
Form type
4
Date filed
1/2/2024, 04:41 PM
Previous filing
Mar 14, 2023
Next filing
Mar 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XENE Common Shares Other $0 -8.4K -50% $0.00 8.4K Dec 29, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred to the Reporting Person's former spouse pursuant to the terms of a settlement agreement dated December 29, 2023 entered into in connection with the dissolution of the Reporting Person's marriage. The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse.